1. Our previous studies demonstrated that when neural stem cells (NSCs) of the C17.2 clonal line are transplanted into the intact or 6-hydroxydopamine (6-OHDA) lesioned rat striatum, in most, but not all grafts, cells spontaneously express the dopamine (DA) biosynthetic enzymes, tyrosine hydroxylase (TH), and aromatic L-amino acid decarboxylase (Yang, M., Stull, N. D., Snyder, E. Y., Berk, M. A., and Iacovitti, L. (2002) . Exp. Neurol.).
INTRODUCTION
The recent isolation of human embryonic stem (ES) cells and the availability of expanded cultures of human neuronal precursor cells (NPCs) have made attractive the goal of cell replacement therapy for neurodegenerative disorders like Parkinson's Disease (PD) (Bjorklund and Lindvall, 2000) . Because these stem/precursor cells can self-renew, they potentially provide an inexhaustible supply of homogeneous cells, all theoretically with the potential to uniformly differentiate into cells of the same desired phenotype. In PD, it is the differentiation of stem cells into neurons of a dopaminergic (DA) phenotype that is necessary to replace the progressively degenerating brainstem DA neurons in the substantia nigra (for review ; Hornykiewicz, 1998) .
Determining which factors are involved in the differentiation of a DA phenotype has been a major focus of our laboratory and that of many others over the last decade. Thus, a number of protocols have been developed to coax stem/precursor cells to express DA traits, such as, the biosynthetic enzyme, tyrosine hydroxylase (TH), both in vitro (Bjorklund et al., 2002 , Carvey et al., 2001 Du and Iacovitti, 1995; Iacovitti et al., 2001; Iacovitti and Stull, 1997; Kawasaki et al., 2000; Lee et al., 2000; Miyazono et al., 1996; Nishino et al., 2000; Stull et al., 2001; Wagner et al., 1999; Yan et al., 2001 ) and in vivo (Bjorklund et al., 2002; Deacon et al., 1998; Kim et al. 2002; Studer et al., 1998; Svendsen et al., 1997) . In all of these cases, however, the differentiation of even a fraction of the cells into TH-expressing neurons, has required considerable genetic (insertion of a Nurr 1 transgene) and/or environmental (treatment with growth factors, conditioned media, etc.) manipulation (Wagner et al., 1999) . Until recently, when we found somewhat unexpectedly, that under certain conditions, stem cells can spontaneously differentiate into neurons that express DA traits following their transplantation into the rat (Yang et al., 2002) . Consequently, when mouse neural stem cells (NSCs) of the C17.2 clonal line were transplanted into intact or 6-hydroxydopamine (6-OHDA) lesioned rats, in more than half of the cases, NSCs withdrew from the cell cycle, migrated extensively in the host brain, exhibited neuronal markers, and by 2-5 weeks, expressed the DA enzymes, TH, and aromatic L-amino decarboxylase acid (AADC). Although in those grafts where DA traits were observed, essentially all transplanted NSCs of the C17.2 line expressed TH (Yang et al., 2002) , in a significant number of grafts, no cells expressed the enzyme. Since these results were observed regardless of whether cells were transplanted into intact or DA depleted rats, it suggested that other factors may have been more influential in deciding the fate of transplanted stem cells.
Thus, in the present study, we sought to refine the conditions in vitro and in vivo in an effort to better determine those that best supported the development of DA and other neurotransmitter traits in NSCs. To do so, we examined whether variations in culture (confluence, passage number) and/or in vivo (degree, type, and site of injury) circumstances affected the survival, migration, and differentiation of NSCs after their transplantation.
METHODS

Tissue Culture
C17.2 neural stem cells, derived initially from the external germinal layer of mouse neonatal cerebellum (Snyder et al., 1992) were immortalized with a v-myc oncogene, transduced with a lac Z gene encoding the β-galactosidase (β-gal) protein and propagated in culture (Kitchens et al., 1994 ). In the experiments described here, C17.2 cells were grown in culture according to procedures described previously (Snyder et al., 1992; Yang et al., in press) with the exception that cells were maintained in culture at differing levels of confluence (30->100%). Cells were fed twice weekly and passaged once per week. After 5-28 passages, cells were harvested (Versene; 3-5 min, RT); spun at low speed (<1000 RPM; resuspended in Hank's BSS with added glucose (6 mg/mL) and glutamine (204 µg/mL) at a final concentration of 2.5 × 10 5 cells/5 µL and then used for transplantation.
Lesioning Methods
Rats received a unilateral injection of 6-OHDA into the right medial forebrain bundle (20 µg/mL in 4 µL PBS containing 0.2 mg/mL ascorbate at AP: −4.4 mm, ML: −1.2 mm, DV: −7.8 mm from bregma) using methods described previously (Jin and Iacovitti, 1995) . Lesions were verified 4-8 weeks later in an automated rotometer system following 5 mg/kg i.p. amphetamine. Only rats with a stable rotation score (5-7 rotations/min for partial or >10 rotations/min for full lesions) after two behavioral tests were used in transplantation studies.
Transplantation Studies
C17.2 cells grown either in low or high confluence were deposited (2.5 × 10 5 cells/ 5 µL) in the cerebral cortex at a position close to the brain's surface near the needle entry site (2.5 µL) and in the body of the striatum (5 µL) of an intact rat or on the side ipsilateral (AP: +1.2 mm, ML: +2.7 mm, DV: −5.4 mm) or contralateral AP: +1.2 mm, ML: +2.7 mm, DV: −4.9 mm) to a 6-OHDA lesion. All transplant recipients received cyclosporin A (10 mg/kg IP) 5 times per week, beginning 1 day before transplantation.
Immunocytochemistry
Rats were perfused with 500 mL of cold (4
• C) periodate-lysine-paraformaldehyde (4%). Brains sections were cut at 30 µm on a freezing microtome and processed for immunocytochemistry using methods described previously (Yang et al., 2002) . Using the following polyclonal rabbit antibodies (rAb) or monoclonal mouse antibodies (mAb): rAb to TH (Protos; 1:1500); rAb to AADC (Protos; 1:800); mAb to DBH (Protos: 1:1000), rAb to GAD (Chemicon: 1:1000), rAb to serotonin (DiaSorin; 1:10,000); rAb to ChAT (Chemicon; 1:3000); mAb to ß-tubulin III (kind gift of J. Provencio; 1:40).
RESULTS
Cell Confluence Affects the Morphology of C17. 2 NSCs in Culture
Cells were established and maintained in culture either (1) at low confluence (<50%) similar to other published studies where the preponderence of cells developed into glia after transplantation (Snyder et al., 1997) or (2) at high confluence (>100%) similar to our earlier studies where, in most cases, cells in the graft acquired a neuronal morphology (Yang et al., 2002) . When cultures of varying confluence were examined and compared, their morphology was remarkably different in terms of the individual cell types present as well as the overall appearance of the culture. When NSCs were maintained at low confluence, flattened polygonal shaped cells were observed scattered nonuniformly throughout the flask ( Fig. 1(A) ). When cells were allowed to reach higher levels of confluence, the bed of polygonal cells became nearly obscured by an overlying layer of fusiform shaped cells bearing long processes ( Fig. 1(B) ). These latter cells tended to line up adjacent to one another to form a swirling pattern. At greater than 100% confluence, the fusiform cell population became difficult to maintain in vitro as many cells floated up and died after 5-7 days in vitro ( Fig. 1(C) ). When dead cells were rinsed from the culture, the spaces between remaining healthy fusiform cells revealed a bed of underlying polygonal cells, similar to those seen at low confluence. Cells passaged from high confluence cultures reattached to the flask as a layer of individual polygonal cells and then developed again into a two-cell layer system within 5 days of passage. Neither cells grown at low nor high confluence ever expressed TH in culture.
Cells Grown at Low Confluence Migrate but Do Not Become Neurons or Express TH following Transplantation
The survival and integration of NSCs, which carry a lac Z marker gene (Snyder et al., 1992) , was tracked for up to 4 weeks after transplantation by immunocytochemical localization of β-galactosidase (β-gal). We found that cells grown at low confluence (<50%) tended to display a relatively immature morphology following engraftment in the 6-OHDA lesioned striatum, with small cell bodies and short branched processes ( Fig. 2(A) ). Possibly because of their relative immaturity, these cells moved extensively in the brain to become widely distributed throughout the striatum ( Fig. 2(B) ). Although NSCs entered surrounding white fiber tracks (anterior commissure, corpus callosum), they did not cross through them to reach adjacent structures (like the cerebral cortex) or to the opposite side of the brain (contralateral striatum). Importantly, following engraftment, no NCSs derived from low confluence cultures (passages 7-22) differentiated in the graft to express the neuronal-specific marker, β-tubulin III (data not shown) or the DA enzyme TH (Fig. 2(C) ) (0 of 8 cases).
Cells Grown at High Confluence in Culture are Competent to Become Neurons and Express TH after Transplantation into the Brain
In contrast with low confluence cultures, NSCs grown at high confluence migrated less robustly in the transplanted brain, with a great many cells remaining in Fig. 1 . Phase-contrast photomicrograph of C17.2 NSCs grown in culture at low (<50%) (A) or high (>100%) (B) confluence levels. At low confluences, the culture is comprised of flattened polygonal cells. While at high confluence levels, both polygonal cells and an overlying bed of fusiform cells are present. At overconfluence (C), many fusiform cells floated up and died after 7 days in vitro (A-C, 20X).
Fig. 2.
Immunocytochemical localization of β-gal in NSCs grown at low confluence (<50%) and then transplanted for 3 weeks into the striata of 6-OHDA lesioned rats (A, 40X; B, 10X). Cells exhibited an immature morphology but migrated extensively. However, NCSs derived from low confluence cultures did not differentiate in the graft to express the neuronal-specific marker, or the DA enzyme TH (C, 10X).
the graft proper even as others moved away from the site of transplantation. As seen previously (Yang et al., in press) , in the majority of these cases, transplants were comprised of neurons which were able to express TH (Fig. 3) . Individual TH + neurons assumed a surprising variety of different morphologies by 3 weeks posttransplantation. In some cases, cells appeared as mature DA neurons with a large elliptical cell body, a large eccentric nucleus and single or multiple branched processes (Fig. 3(A) ). In others, TH-expressing NSCs acquired a more epithelial type appearance with flattened sheet-like processes (Fig. 3(B) ). In yet other grafts, TH + cells exhibited a less mature morphology with a smaller cell body and short cork-screw-shaped ( Fig. 3(C) ) or highly branched (Fig. 3(D) ) processes. Although NSC morphology tended to be consistent within an engrafted region, it differed greatly from one region to another, even within the same brain. Thus, engrafted NSCs in cortex might resemble one type while NSCs in the body of a striatal graft or those scattered throughout the striatum might assume an entirely different shapes. We consistently found that NSCs that resided nearer to the cerebrospinal fluid (CSF) compartment appeared more mature (similar to Fig. 3(A), (B) ) than did those that had migrated to take up residence in the host parenchyma (similar to Fig. 3(C), (D) ).
Competent NSCs of the C17.2 Line Express TH after Transplantation but Only When There Is Concomitant Physical Damage to the Brain
Although our findings to this point suggested that cells grown under conditions of prolonged high confluence in culture were competent to express TH following their transplantation into the 6-OHDA lesioned striatum, the fact that some grafts did not contain TH-expressing NSCs indicated that factors in vivo were also crucial in this regard. Indeed, our earlier studies suggested that DA differentiation occurred independent of whether NSCs were transplanted into the intact or DA depleted brain (Yang et al., in press ). Instead, the notion was raised that local factors might critically affect the chemical milieu of the graft and ultimately the final differentiation of transplanted cells. To explore this possibility, cells believed to be competent to express TH (i.e. grown continuously at >100% confluence) were harvested at various passages (3-32) and transplanted into the striatum and cerebral cortex of intact rats or rats with a partial (5-7 rotations per min) or full (>10 rotations per min) 6-OHDA lesion, either on the side ipsilateral or contralateral to the lesion (see Methods). Animals were sacrificed 2-5 weeks hence and the survival, migration and differentiation of neurotransmitters traits were assessed with respect to the degree to which physical injury of the brain had occurred during the transplantation process.
We found that in 26 of 40 grafts (65%) C17.2 cells survived long-term in vivo. In those grafts where cells had died, NSCs appeared rounded up with condensed nuclei. Unlike healthy grafts (Fig. 4(A) ), dying NSCs were oftentimes surrounded on all sides by reactive hypertrophic GFAP + astrocytes (Fig. 4(B) ). These glia appear to be of host rather than stem cell origin since they did not stain with B-gal (see insets). Of the 26 grafts which did survive, TH-expressing β-gal + NSCs were observed in 17 cases (65%) regardless of (a) whether cells were transplanted into the rat striatum (Str) (Fig. 5(A) -(R)) or cerebral cortex (CC) (Fig. 6(A)-(I) ) or (b) whether they were placed in the intact (N = 2) brain; on the side contralateral (N = 2) (Fig. 5(M) -(R); Fig. 6(G)-(I) ) or ipsilateral to a partial (N = 8) (Fig. 5(G)-(L) ) or full 6-OHDA lesion (N = 5) (Fig. 5(A)-(F); Fig. 6(A)-(F) ), suggesting again that neither lesion status nor transplantation site influenced the differentiation of TH in NSCs. Importantly, we found that TH-expressing NSCs were present only in grafts derived Fig. 4 . Immunocytochemical localization of GFAP and B-gal in NSCs derived from high confluence cultures 2-5 weeks after transplantation. In healthy grafts (A, 20X) there were occasional astrocytes present at the border of the graft (arrow). In contrast, in grafts where most of the NSCs had died (B, 20X), grafts were surrounded by reactive hypertrophic astrocytes (arrow). Sections were counterstained for Nissl with a thionin stain. B-gal staining was not found in the area where host reactive glia were observed (see insets), suggesting that the glia were of host not stem cell origin.
from cells grown at high confluence for a minimum of 12 passages and not beyond 20 passages.
Of particular noteworthiness was the fact that all TH-expressing grafts, both in the cortex and striatum, were accompanied by marked tissue damage, principally at the needle entry site (see Fig. 6(A), (D) , (G)). Conversely, in those brains where high confluence C17.2 cells survived engraftment but did not express TH, there was little evidence of physical disruption to the brain. Only in two cases was significant brain injury observed in the absence of TH induction in NSCs and, in both instances, transplanted cells had been maintained at high confluence but for an insufficient number of passages (<15). Taken together, these findings suggest that TH differentiation is dependent on multiple factors in vitro and in vivo.
NSCs of the C17.2 Line Did Not Exhibit Traits of Other Neurotransmitter Systems
To determine whether NSCs grown under conditions believed to be ideal for DA differentiation also developed traits of other neurotransmitter systems, NSCs derived from high confluence, high passage cultures were transplanted either to the cerebral cortex or striatum of a 6-OHDA lesioned rat and sacrificed 4 weeks later. Adjacent or near adjacent brain sections from the same rat brain were then stained for β-gal and for markers of a variety of different brain neurotransmitter systems. As seen in Fig. 7 , NSCs stained positively for β-gal (A, B), TH (C, D), and AADC (data not shown) but not indices of other neurotransmitter systems, such as dopamine-β-hydroxylase (E, F), choline acetyl-transferase (G, H), serotonin (I, J), or glutamic acid decarboxylase (K, L). The failure to stain NSCS was not due to a lack of antibody specificity since positively labeled host neurons were found in locations predicted by neurotransmitter content (data not shown). 
DISCUSSION
The results of the present study suggest that the expression of DA phenotypic traits in transplanted stem cells is regulated in a complex fashion, involving both the development of cell intrinsic mechanisms and the influence of outside environmental cues. While optimal intracellular and extracellular conditions appear to be necessary, neither alone is sufficient to induce the differentiation of DA traits in transplanted stem cells in this paradigm.
Of unforeseen importance was the fact that the life history of an NSC in culture would greatly impact the final fate of cells after harvest and transplantation in vivo. Given that C17.2 stem cells are derived from a well-established immortalized line of homogeneous cells (Kitchens et al., 1994; Snyder et al., 1992) , we did not anticipate that their differentiative potential in vivo would vary with their time and growth conditions in culture. However, the present studies demonstrate that the confluence at which C17.2 cells are maintained in culture and the number of passages they undergo directly affect their integration and differentiation following engraftment in the rat brain. Cells grown continuously in low confluence (polygonal cells) and transplanted into the brain, migrate extensively but remain relatively immature in appearance and do not express DA differentiation traits. This is consistent with previous in vivo findings from a number of other laboratories in which C17.2 cells were carried as low confluence, low passage cultures (Akerud et al., 2001; Snyder et al., 1997; Wagner et al., 1999) . In these studies, as in ours, cells integrated remarkably well but did not express DA traits unless, prior to transplantation, they were first genetically transduced to overexpress the nuclear receptor Nurr 1 and later grown on glial-derived factors (Wagner et al., 1999) .
In contrast, when cells in the present study were maintained at high confluence (polygonal and fusiform cells), they spontaneously differentiated to express TH, raising the possibility that these cells naturally developed intrinsic mechanisms similar to those genetically engineered into cells in the study by Wagner et al. (1999) . Possibly, highly confluent cells manufacture and secrete growth factors in sufficient quantity to promote their own maturation, causing a change in their appearance and potentiality after transplantation. Several of our observations of grafts derived from high confluence, high passage cultures support this notion, including that (1) many NSCs are well developed morphologically (large soma and nucleus; long and abundant processes); (2) these cells tend to stay confined to the graft proper, behaving more like older fetal neurons in a transplant (Emgard et al., 1999; Kopin et al., 1993) , and (3) only NSCs that have been passaged 12-20 times in vitro are able to respond to TH-inducing cues in vivo, possibly as they develop the appropriate receptors and/or signaling molecules.
The relationship between cell type in culture and behavior in vivo, however, remains tenuous. Since fusiform cells are present only in high confluence cultures and since only grafts derived from high confluence cultures contain TH-expressing cells, one possibility is that the former gives rise to the latter. If so, however, it raises questions about the fate of polygonal cells also present in these cultures and in the cell suspension derived from them for injection into the brain. Since virtually all NSCs of the C17.2 line express TH in these grafts (Yang et al., 2002) , it suggests that either polygonal cells from high confluence cultures also express TH, or alternatively, that they do not survive transplantation. In either case, it would directly contradict the behavior of polygonal cells derived from low confluence cultures, where cells survive engraftment well but do not express TH. Regardless of which cell type (or types) ultimately develop into TH expressing neurons in the graft, it is clear that experiences acquired in vitro markedly affect their phenotypic potentiality in vivo.
Nonetheless, even with appropriate "priming" in culture, not all grafts of C17.2 cells are capable of TH expression, suggesting that in vivo cues are also of critical importance. Along these lines, it has recently been suggested that it is the loss of a particular cell type (Doering and Snyder, 2000; Nishino et al., 2000) , such as DA neurons in a 6-OHDA lesioned brain, which guides transplanted stem cells in the appropriate differentiation. Arguing against this supposition, however, is the fact that, in the present study, the differentiation of DA traits in engrafted NSCs occurs regardless of whether cells are transplanted into the intact, partially or fully lesioned striatum. Also, of little impact on neurotransmitter phenotypic choice of NSCs regardless of how they were grown in culture prior to transplantation, is the site into which stem cells are implanted. Despite the fact that C17.2 cells oftentimes assume the morphological phenotype typical of the region where they reside (e.g. pyramidal NSCs in the cortex) (Snyder et al., 1997; Yang et al., 2002) , the transmitter traits they express are not always context-appropriate. Thus, NSCs exhibit DA traits even if they are transplanted into regions that do not customarily contain DA cell bodies (e.g. cortex), and conversely, NSCs do not express traits of other neurotransmitter systems usually present there (e.g. GABA in the striatum). In fact, transplanted NSCs did not acquire traits of any other neurotransmitter systems that we examined; including the noradrenergic, cholinergic, GABAergic, or serotonergic systems, suggesting either that DA represents the default phenotype of NSCs or that only DA differentiation cues are present posttransplantation.
The former hypothesis, however, does not explain why in some grafts of high confluence, high passage NSCs, do not default to express a TH phenotype. Instead, we favor the latter view, that is, that extrinsic factors present in the transplanted brain primarily instruct NSCs in the DA differentiation process. This is further suggested by the finding that local damage to the brain in the immediate vicinity of the graft is highly correlated with the appearance of TH in stem cells. Certainly, it has long been hypothesized that growth factors from injured neurons and reactive glia affect the survival and growth of transplanted tissue (Cotman et al., 1984; Nieto-Sampedro et al., 1987) . In addition, inflammatory agent cytokines from monocytes, macrophages, and other cells associated with the disruption of the blood brain barrier and exposure to the blood and/or CSF compartments are also implicated in these effects (Carvey et al., 2001; Jonakait et al., 1996 Jonakait et al., , 2000 Ling et al., 1998) . We would propose, based on the findings of this study and given the multiple functions served by these pleiotropic factors during development (mitogenesis, trophism, tropism, and differentiation) (for review; Tessarollo, 1998) , that local injury-induced agents also influence the survival, migration and DA differentiation of stem cells following transplantation.
In summary, the present study has established that engrafted neural stem cells are indeed capable of DA differentiation but only if they are first grown in culture under conditions of repeated high confluence and then transplanted into the brain in proximity to local damage where presumably DA differentiation factors are present. Why these factors specifically promote the differentiation of DA traits in stem cells and how they achieve this end awaits further investigation into their molecular identities and mechanisms of action. Nevertheless, these findings suggest that conditions/factors can be identified that will allow stem cells to someday fulfill their promise of providing an infinite source of replacement tissue for the treatment of Parkinson's Disease.
